No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr16:31262800-31271800 |
Weak transcription |
Primary T helper cells PMA-I stimulated |
--
|
2 |
chr16:31263000-31271000 |
Weak transcription |
Primary T killer memory cells from peripheral blood |
blood
|
3 |
chr16:31263400-31268400 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
4 |
chr16:31264200-31265400 |
Enhancers |
Fetal Intestine Large |
intestine
|
5 |
chr16:31264200-31265600 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
6 |
chr16:31264200-31268200 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
7 |
chr16:31264400-31265400 |
Enhancers |
Duodenum Mucosa |
Duodenum
|
8 |
chr16:31264400-31265400 |
Enhancers |
Duodenum Smooth Muscle |
Duodenum
|
9 |
chr16:31264400-31265400 |
Enhancers |
Fetal Intestine Small |
intestine
|
10 |
chr16:31264400-31265600 |
Flanking Active TSS |
Primary neutrophils fromperipheralblood |
blood
|
11 |
chr16:31264400-31266600 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
12 |
chr16:31264600-31265400 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
13 |
chr16:31264600-31266200 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
14 |
chr16:31264800-31265600 |
Enhancers |
HepG2 |
liver
|
15 |
chr16:31264800-31265800 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
16 |
chr16:31265000-31265400 |
Flanking Active TSS |
Primary B cells from cord blood |
blood
|
17 |
chr16:31265000-31265400 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
18 |
chr16:31265000-31265400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
19 |
chr16:31265000-31265400 |
Flanking Active TSS |
K562 |
blood
|
20 |
chr16:31265000-31265600 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
21 |
chr16:31265000-31265600 |
Enhancers |
Primary T helper 17 cells PMA-I stimulated |
--
|
22 |
chr16:31265000-31265600 |
Flanking Active TSS |
A549 |
lung
|
23 |
chr16:31265000-31265600 |
Enhancers |
GM12878-XiMat |
blood
|
24 |
chr16:31265000-31265600 |
Enhancers |
NHEK |
skin
|
25 |
chr16:31265200-31265400 |
Enhancers |
Primary T regulatory cells fromperipheralblood |
blood
|
26 |
chr16:31265200-31265400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
27 |
chr16:31265200-31265400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
28 |
chr16:31265200-31265400 |
Flanking Active TSS |
Skeletal Muscle Male |
skeletal muscle
|
29 |
chr16:31265200-31265400 |
Enhancers |
Spleen |
Spleen
|
30 |
chr16:31265200-31265600 |
Weak transcription |
Primary T cells fromperipheralblood |
blood
|
31 |
chr16:31265200-31265600 |
Flanking Active TSS |
Primary hematopoietic stem cells |
blood
|
32 |
chr16:31265200-31265600 |
Enhancers |
Hela-S3 |
cervix
|
33 |
chr16:31265200-31265800 |
Enhancers |
Primary mononuclear cells fromperipheralblood |
Blood
|
34 |
chr16:31265200-31270600 |
Weak transcription |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
35 |
chr16:31265200-31271400 |
Weak transcription |
Right Atrium |
heart
|
36 |
chr16:31265200-31271600 |
Weak transcription |
Skeletal Muscle Female |
skeletal muscle
|
37 |
chr16:31265200-31276600 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|